Related Experiment Videos
From the v-mpl oncogene to thrombopoietin
Summary
Researchers identified the Mpl receptor ligand, a molecule crucial for platelet production. This discovery explains the physiological regulation of thrombopoiesis, involving thrombopoietin (TPO) and megakaryocyte-colony stimulating factor (MK-CSF) activities.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- The myeloproliferative leukemia virus (MPLV) contains the v-mpl oncogene.
- The cellular homolog, c-mpl, encodes a hematopoietic cytokine receptor specific to megakaryocytic differentiation.
Purpose of the Study:
- To isolate and characterize the ligand for the Mpl receptor.
- To determine the physiological role of the Mpl receptor ligand in hematopoiesis.
Main Methods:
- Isolation of cDNAs encoding the Mpl receptor ligand using the Mpl receptor protein.
- In vivo and in vitro studies with recombinant Mpl ligand molecules.
Main Results:
- cDNAs for the Mpl receptor ligand were successfully isolated in multiple species (humans, pigs, dogs, mice).
- The recombinant Mpl ligand molecule demonstrated both thrombopoietin (TPO) and megakaryocyte-colony stimulating factor (MK-CSF) activities.
Conclusions:
- The Mpl ligand, also known as TPO/MK-CSF, is identified as the humoral physiological regulator of platelet production.
- This finding elucidates a key mechanism in megakaryopoiesis and thrombopoiesis.